Signal over Noise in Clinical AI.
Automated, technical due diligence for Healthcare Venture Capital and MedTech Funds.
FC-OE is an independent clinical & translational intelligence firm founded in March 2026 by Dr. med. univ. Felix Conrad Oettl.
Operating at the exact intersection of frontline healthcare and advanced computational data science, FC-OE provides institutional-grade advice for Healthcare Venture Capitalists, MedTech Funds, and AI Startups.
If you subscribe today, you gain immediate access to our proprietary research pipeline, evaluating the commercial and clinical viability of global medical AI.
Unrestricted Intelligence
By upgrading to a professional or institutional tier, you unlock the complete FC-OE Private Library. This includes our full archive of deep-dive reports, breakdowns, pre-print evaluations, and regulatory analyses.
Signal > Noise, Delivered Weekly
We continuously monitor global medical AI research, clinical trials, and foundational model updates so you don't have to. Every week, you receive a highly distilled, clinically validated briefing sent directly to your inbox. No algorithms, no hype, no fluff. Just actionable Alpha.
The Edge
Join a highly curated roster of healthcare allocators, MedTech executives, and clinical KOLs who rely on FC-OE's dual-expertise (MD + Machine Learning) to separate clinical AI reality from vaporware.
Legal & Regulatory Disclaimer
No Medical Advice: The intelligence, research, and analysis published by FC-OE are strictly for B2B informational and educational purposes. Although the founder is a licensed medical professional, no content provided on this platform, in newsletters, or during advisory sessions constitutes medical advice, clinical diagnosis, or treatment recommendations. Engaging with FC-OE does not establish a doctor-patient relationship.
No Investment Advice: FC-OE provides technical and clinical evaluations of medical artificial intelligence, Software as a Medical Device (SaMD), and digital health technologies. This information does not constitute formal financial, investment, legal, or regulatory advice. Venture capital, private equity, and startup investments carry inherent high risks. Subscribers, funds, and clients are solely responsible for conducting their own independent due diligence and consulting with their own financial and legal advisors prior to making any capital allocation or investment decisions.
Institutional Affiliations: The views, analyses, and commercial viability scores expressed by FC-OE are entirely independent. They do not represent, reflect, or imply the official policy, position, or endorsement of any academic, clinical, or corporate institution with which the founder may be affiliated.
Accuracy & Liability: The fields of machine learning, artificial intelligence, and clinical medicine are rapidly evolving. While FC-OE utilizes rigorous methodologies to curate and evaluate data, we make no warranties or representations regarding the absolute accuracy, completeness, or real-time validity of the information provided. FC-OE and its founder assume no liability for any commercial, clinical, or financial actions taken in reliance upon this publication.